Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals - Maeda, Kenji; Amano, Masayuki; Uemura, Yukari; Tsuchiya, Kiyoto; Matsushima, Tomoko; Noda, Kenta; Shimizu, Yosuke; Fujiwara, Asuka; Takamatsu, Yuki; Ichikawa, Yasuko; Nishimura, Hidehiro; Kinoshita, Mari; et al. (Scientific reports, 2021)
Keywords: 631/250/255/2514; 631/326/590/2293; 631/326/596/4130; Adult; Aged; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - immunology; Antibodies, Neutralizing - pharmacology; Antibodies, Viral - blood; Antibodies, Viral - immunology; Antibody response; BNT162 Vaccine - adverse effects; BNT162 Vaccine - pharmacokinetics; COVID-19; COVID-19 - blood; COVID-19 - immunology; COVID-19 Vaccines - adverse effects; COVID-19 Vaccines - pharmacokinetics; Drug-Related Side Effects and Adverse Reactions; Female; Humanities and Social Sciences; Humans; Immune response; Immunogenicity, Vaccine - immunology; Immunoglobulin G; Immunologic Tests; Japan; Kinetics; Male; Middle Aged; mRNA; multidisciplinary; Neutralization; Prospective Studies; SARS-CoV-2 - genetics; SARS-CoV-2 - immunology; SARS-CoV-2 - pathogenicity; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Side effects; Vaccines; Virions; Japan